Association Between Genetic Polymorphisms of ACE & ENOS and Diabetic Nephropathy

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2014 Sep 18

PMID 25227524

Citations 6

Authors

P Huo

D Zhang

X Guan

Y Mei

H Zheng

X Feng

Affiliations

Soon will be listed here.

Abstract

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, with multiple genetic and environmental factors involving in its etiology. ACE and eNOS gene were considered to have important roles in the development and progression of DN. In this study, a case-control study was carried out to investigate the effects of 7 SNPs in ACE gene and 2 SNPs in eNOS gene in the development of DN in Northern China.7 SNPs including A240T, A2350G, A5466C, A2215G, T3892C, C1237T and C3409T of ACE gene and 2 SNPs (G894T and T786C) of eNOS gene were genotyped by polymerase chain reaction restriction fragment length polymorphism method. 431 type 2 diabetic patients with nephropathy (cases) were compared to 420 type 2 diabetic patients without nephropathy (controls) in the study. Data were analyzed by SPSS 17.0 and HaploView software. The frequency distribution of A2350G, 4 haplotyps in ACE gene and G894T in eNOS gene were demonstrated to be different between case and control groups significantly. Whereas other SNPs and haplotypes had no differences in two cohorts. The results revealed that variations of ACE and eNOS gene had association with DN, which indicated ACE and eNOS gene may play an important role in pathogenesis of DN in Northern Chinese Han population.

Citing Articles

Association between nitric oxide synthase T-786C genetic polymorphism and chronic kidney disease: Meta-analysis incorporating trial sequential analysis.

Hsiao P, Chiu C, Tsai D, Ko P, Chen Y, Cheng H PLoS One. 2021; 16(10):e0258789.

PMID: 34662360 PMC: 8523046. DOI: 10.1371/journal.pone.0258789.

Association of eNOS and MCP-1 Genetic Variants with Type 2 Diabetes and Diabetic Nephropathy Susceptibility: A Case-Control and Meta-Analysis Study.

Raina P, Sikka R, Gupta H, Matharoo K, Bali S, Singh V Biochem Genet. 2021; 59(4):966-996.

PMID: 33609191 PMC: 7896546. DOI: 10.1007/s10528-021-10041-2.

Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy.

Marquardt A, Al-Dabet M, Ghosh S, Kohli S, Manoharan J, Elwakiel A J Am Soc Nephrol. 2017; 28(11):3182-3189.

PMID: 28696246 PMC: 5661274. DOI: 10.1681/ASN.2016101123.

Correlation of Endothelial Nitric Oxide Synthase Gene Polymorphism (GG, TT and GT Genotype) with Proteinuria and Retinopathy in Type 2 Diabetic Patients.

Momeni A, Hashemzadeh Chaleshtori M, Saadatmand S, Kheiri S J Clin Diagn Res. 2016; 10(2):OC32-5.

PMID: 27042499 PMC: 4800565. DOI: 10.7860/JCDR/2016/14975.7291.

Association of ACE polymorphism and diabetic nephropathy susceptibility.

Ma H, Yu C, Wang R Int J Clin Exp Med. 2015; 8(2):2962-5.

PMID: 25932264 PMC: 4402911.

References

Agius E, Attard G, Shakespeare L, Clark P, Vidya M, Hattersley A . Familial factors in diabetic nephropathy: an offspring study. Diabet Med. 2006; 23(3):331-4. DOI: 10.1111/j.1464-5491.2006.01803.x. View

Noiri E, Satoh H, Taguchi J, Brodsky S, Nakao A, Ogawa Y . Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002; 40(4):535-40. DOI: 10.1161/01.hyp.0000033974.57407.82. View

Prabhakar S . Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004; 24(4):333-44. DOI: 10.1016/j.semnephrol.2004.04.005. View

Heesom A, Hibberd M, Millward A, Demaine A . Polymorphism in the 5'-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes. 1997; 46(2):287-91. DOI: 10.2337/diab.46.2.287. View

Kaufman K, Kelly J, Gray-McGuire C, Asundi N, Yu H, Reid J . Linkage analysis of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and systemic lupus erythematosus. Mol Cell Endocrinol. 2001; 177(1-2):81-5. DOI: 10.1016/s0303-7207(01)00424-5. View

Gong A, Li X, Wang Y, Yan H, Xu Z, Feng Z . Association study of ACE polymorphisms and systemic lupus erythematosus in Northern Chinese Han population. Mol Biol Rep. 2012; 39(10):9485-91. DOI: 10.1007/s11033-012-1813-7. View

Wang F, Fang Q, Yu N, Zhao D, Zhang Y, Wang J . Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects. J Renin Angiotensin Aldosterone Syst. 2011; 13(1):161-74. DOI: 10.1177/1470320311417655. View

Shin Y, Baek S, Chang K, Park C, Yang C, Jin D . Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract. 2004; 65(3):257-65. DOI: 10.1016/j.diabres.2004.01.010. View

Purnamasari D, Widjojo B, Antono D, Syampurnawati M . ACE gene polymorphism and atherosclerotic lesion of carotid artery among offsprings of type 2 diabetes mellitus. Acta Med Indones. 2012; 44(2):128-34. View

10.

Currie D, McKnight A, Patterson C, Sadlier D, Maxwell A . Investigation of ACE, ACE2 and AGTR1 genes for association with nephropathy in Type 1 diabetes mellitus. Diabet Med. 2010; 27(10):1188-94. DOI: 10.1111/j.1464-5491.2010.03097.x. View

11.

Lely A, Luik P, Navis G . Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?. Curr Diabetes Rev. 2008; 3(1):41-52. DOI: 10.2174/157339907779802049. View

12.

Prabhakar S . Pathogenic role of nitric oxide alterations in diabetic nephropathy. Curr Diab Rep. 2005; 5(6):449-54. DOI: 10.1007/s11892-005-0054-8. View

13.

Seaquist E, Goetz F, Rich S, Barbosa J . Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989; 320(18):1161-5. DOI: 10.1056/NEJM198905043201801. View

14.

Zanchi A, Moczulski D, Hanna L, Wantman M, Warram J, Krolewski A . Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int. 2000; 57(2):405-13. DOI: 10.1046/j.1523-1755.2000.00860.x. View

15.

Tavakkoly Bazzaz J, Amoli M, Pravica V, Chandrasecaran R, Boulton A, Larijani B . eNOS gene polymorphism association with retinopathy in type 1 diabetes. Ophthalmic Genet. 2010; 31(3):103-7. DOI: 10.3109/13816810.2010.482553. View

16.

Li X, An J, Guo R, Jin Z, Li Y, Lu F . Association of the genetic polymorphisms of the ACE gene and the eNOS gene with lupus nephropathy in northern Chinese population. BMC Med Genet. 2010; 11:94. PMC: 2903533. DOI: 10.1186/1471-2350-11-94. View

17.

Nawaz S, Hasnain S . Association of ACE ID and ACE G2350A polymorphism with increased blood pressure in persons exposed to different sound levels in Pakistan. Int Arch Occup Environ Health. 2011; 84(4):355-60. DOI: 10.1007/s00420-011-0619-6. View

18.

Qi Y, Niu W, Zhu T, Zhou W, Qiu C . Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-Tibet altitude. Eur J Epidemiol. 2007; 23(2):143-52. DOI: 10.1007/s10654-007-9208-0. View

19.

Akcay A, Sezer S, Ozdemir F, Arat Z, Atac F, Verdi H . Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation. 2004; 78(6):892-8. DOI: 10.1097/01.tp.0000134972.81306.b1. View

20.

Hwang S, Tsai J, Chen H . Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010; 15 Suppl 2:3-9. DOI: 10.1111/j.1440-1797.2010.01304.x. View